LifeStance Health (LFST) Change in Accured Expenses (2020 - 2026)

LifeStance Health (LFST) has 7 years of Change in Accured Expenses data on file, last reported at $9.8 million in Q1 2026.

• Quarterly Change in Accured Expenses rose 322.48% year-over-year to $9.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.2 million (up 5.1% YoY) and the FY2025 annual result came in at -$5.9 million, down 139.54% from the prior year.
• Change in Accured Expenses rose to $9.8 million in Q1 2026 per LFST's latest filing, from -$2.2 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $17.3 million in Q2 2024 and bottomed at -$17.3 million in Q4 2022.
• The 5-year median for Change in Accured Expenses is $2.8 million (2024), against an average of $1.8 million.
• The widest annual swing landed in 2022, when Change in Accured Expenses slumped 891.65%; it then jumped 442.84% in 2024.
• Tracing LFST's Change in Accured Expenses over 5 years: stood at -$17.3 million in 2022, then surged by 114.98% to $2.6 million in 2023, then surged by 83.83% to $4.8 million in 2024, then slumped by 147.05% to -$2.2 million in 2025, then soared by 536.4% to $9.8 million in 2026.
• Per Business Quant, the three latest LFST Change in Accured Expenses figures stand at $9.8 million (Q1 2026), -$2.2 million (Q4 2025), and -$3.6 million (Q3 2025).

Peer Comparison